CDC Website CDC Website

To Join the NPIN community or

Home » Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed)

Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites research grant applications to study the cellular and molecular mechanisms delineating the neuropathophysiology of HIV-associated neurological disorders (HAND) in the setting of long-term combination antiretroviral therapy (cART) conditions using induced microglia and cerebral organoids generated from patient derived induced pluripotent stem cell (iPSC) lines.

Funding Organization
Funding Category
Locations
National
Eligible Organizations
Number of Awards Given
Up to 7 awards.
Award Amount Notes
NIH intends to fund an estimate of 7 awards in response to this FOA and the companion R21 FOA, corresponding to a total of $2,500,000, for fiscal year FY19. Future year amounts will depend on annual appropriations.
Letter of Intent Date
11/18/18
Application Due Date
12/18/18
Project Start Date
7/1/19
Application Contact
Cheryl
Nathaniel
Grants Management Specialist
301-827-6703
nathanic@nida.nih.gov
Technical Contact
Da-Yu
Wu, PhD
Health Scientist Administrator
wudy@mail.nih.gov
301-435-4649
Fund Duration
The maximum project period is 5 years.
Subjects
Audiences
Focus Area

Fund Number: 

5417

Fund ID: 

RFA-DA-19-009

Last Updated: 

9/12/18